Pre-transfusion testing ensures compatibility between the transfusion patient and the blood component(s) (red blood cells, platelets, plasma) intended for transfusion. This process includes accurate and thorough completion of the requisition, accurate patient identification, proper collection and labelling of the blood sample from the patient, laboratory testing to determine the patient’s blood group and to identify the presence of red blood cell alloantibodies, and compatibility testing. Pre-transfusion testing is complete when a compatible blood component is identified and labelled for transfusion to the intended patient. This chapter provides an overview of the pre-transfusion tests that are routinely performed.
A new monthly OTDT digest has been developed to share highlights from our collaborative work with the organ and tissue donation and transplantation community. Please send contributions, comments and suggestions to firstname.lastname@example.org
The Canadian Clinical Guide to Organ Donation is an organ donation curriculum for health professionals that enhances competencies in the identification and care of potential deceased donors and their families. The Canadian Clinical Guide to Organ Donation is a free self-directed, interactive, online e-learning course featuring case scenarios.
Developed by Canadian Blood Services, the Canadian Transplant Registry (CTR) is the technology that will operationalize the IPOS Heart policies. The CTR is an easily accessible online website for Organ Donation Organizations, laboratories, and transplant hospitals to manage patients, donors, organ offers and transplant outcomes. The CTR will apply a standardized matching and ranking algorithm to optimize transplant success factors for those hard to match and/or medically urgent heart patients.
Building upon the success of the interprovincial sharing of kidneys for highly sensitized patients, and guided by Canada's heart transplantation community, Canadian Blood Services is now developing the technology that supports the approved national Heart sharing policies that will streamline and propel heart allocation and transplantation in Canada in to the future.
The Canadian Transplant Registry (CTR) identifies transplant opportunities across Canada for heart transplant candidates who are highly sensitized to Human Lymphocyte Antigens (HLA) and/or designated as medically urgent (i.e., designated as medical status 4).
This policy describes the eligibility requirements for potential transplant recipients to participate in the Inter-provincial Sharing: Heart program. View the policy here.